Analysis of Genetic Variants in Never-Smokers with Lung Cancer Facilitated by an Internet-Based Blood Collection Protocol: A Preliminary Report
暂无分享,去创建一个
N. Girard | A. Viale | M. Ladanyi | M. Kris | C. Azzoli | W. Pao | R. Klein | K. Matsuo | M. Robson | K. Nafa | Y. Yatabe | V. Miller | I. Orlow | Gregory Riely | M. Harlan | E. Lou | R. Reddy
[1] WHO histological classification of tumours of the vulva , 2011 .
[2] Chronic Disease Division. Cancer facts and figures , 2010 .
[3] Chien-Jen Chen,et al. Association of an EGFR intron 1 SNP with never-smoking female lung adenocarcinoma patients. , 2009, Lung cancer.
[4] I. Wistuba,et al. Germ-line and somatic presentations of the EGFR T790M mutation in lung cancer. , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[5] L. Clegg,et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study , 2008, Cancer Causes & Control.
[6] C. Sima,et al. Pack years of cigarette smoking as a predictor of survival in 2,013 patients with stage IIIb/IV non-small cell lung cancer (NSCLC) , 2008 .
[7] G. Mills,et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 , 2008, Nature Genetics.
[8] Daniel F. Gudbjartsson,et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease , 2008, Nature.
[9] Paolo Vineis,et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.
[10] G. Bepler,et al. The feasibility of online genetic testing for lung cancer susceptibility: uptake of a web-based protocol and decision outcomes , 2008, Genetics in Medicine.
[11] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[12] W. Pao,et al. Development of New Mouse Lung Tumor Models Expressing EGFR T790M Mutants Associated with Clinical Resistance to Kinase Inhibitors , 2007, PloS one.
[13] Marshall W. Anderson,et al. EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity. , 2007, Cancer research.
[14] L. Holmberg,et al. Lung cancer incidence in never smokers. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.
[16] H. Koong,et al. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] M. Spitz,et al. Never smokers and lung cancer risk: A case‐control study of epidemiological factors , 2006, International journal of cancer.
[18] A. Gazdar,et al. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers , 2006, International journal of cancer.
[19] Stat bite: Causes of lung cancer in nonsmokers. , 2006, Journal of the National Cancer Institute.
[20] R Doll,et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies , 2004, BMJ : British Medical Journal.
[21] Gayatry Mohapatra,et al. Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR , 2005, Nature Genetics.
[22] Sandra A. Moore,et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. , 2005, Cancer cell.
[23] H. Varmus,et al. Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain , 2005, PLoS medicine.
[24] Elisabeth Brambilla,et al. Pathology and genetics of tumours of the lung , pleura, thymus and heart , 2004 .
[25] R. Wilson,et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[26] Karl-Heinz Jöckel,et al. Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: A pooled analysis of two large studies , 2004, International journal of cancer.
[27] P. Vineis,et al. CYP1A1 T3801 C polymorphism and lung cancer: A pooled analysis of 2,451 cases and 3,358 controls , 2003, International journal of cancer.
[28] P. Dayer,et al. Point: myeloperoxidase -463G --> a polymorphism and lung cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[29] L. Marchand,et al. Erratum: Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk (Carcinogenesis (2002) vol. 23 (1343-1350)) , 2002 .
[30] L. Le Marchand,et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. , 2002, Carcinogenesis.
[31] E. Berg,et al. World Health Organization Classification of Tumours , 2002 .
[32] J H Ho,et al. Worldwide epidemiological patterns of lung cancer in nonsmokers. , 1990, International journal of epidemiology.